Breaks Categories: Stock Spotlights

MondayJul 29, 2019 3:00 pm

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Gains Approval for Listing of Debentures, Warrants on the CSE

Plus Products (CSE: PLUS) (OTCQX: PLPRF) recently announced the listing of its debentures and warrants from its brokered private placement on the Canadian Securities Exchange under ticker symbols ‘PLUS.DB’ and ‘PLUS.WT’ on July 2, 2019 (http://cnw.fm/nL9u3). An article discussing the company reads, “The warrants and debentures were part of a private placement that raised CA$25 million, with the funds to be used for working capital and other general corporate purposes. . . . The private placement of unsecured convertible note units closed on February 28 (http://cnw.fm/0YuX3). The brokered private placement of 25,000 units of the company at a price of…

Continue Reading

FridayJul 26, 2019 3:12 pm

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Upholds Commitment to Quality amid CBD Shortage

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, remains dedicated to maintaining its high standards in the midst of a growing cannabis supply gap. An article discussing the company reads, “TGOD is one of three organic cannabis growers in Canada. No synthetic pesticides or fertilizers are used in the company’s growing process. The company is also dedicated to creating a smaller environmental footprint by using less water and energy, low-cost power solutions and smarter efficient packaging. By growing organically and at low costs, TGOD’s final product demands a premium in the market, thereby…

Continue Reading

TuesdayJul 23, 2019 3:08 pm

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Joint Development Agreement to Create Biosynthesis Platform for CBD Production, Distribution

Willow Biosciences (CSE: WLLW) recently entered a joint development agreement (“JDA”) with leading cannabinoid manufacturer Noramco Inc. to develop a yeast-based biosynthesis platform for the production and distribution of cannabidiol (“CBD”) (http://cnw.fm/KZdi0). An article further discussing the company reads, “The JDA is mutually exclusive and creates an enviable arrangement designed to take advantage of each company’s unique and compelling skill sets, the news release notes. The JDA requires each company to cover its own costs, retain its own intellectual property associated with its own scopes of work and share equally in the gross profits from sales of CBD produced under the…

Continue Reading

TuesdayJul 23, 2019 2:52 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Remains Ahead of the Pack with Innovative Delivery Technology

Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is the developer of the drug-delivery platform DehydraTECH(TM). The company’s innovative technology promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. An article discussing the company reads, “One of the delivery challenges is the amount of CBD waste created, because the human body can only absorb a small amount of the molecules. DehydraTECH is disrupting this cycle by protecting the product during stomach transit, amplifying intestinal absorption by five to ten times over traditional methods and enabling the drug to bypass first-pass liver metabolism. Third-party lab studies…

Continue Reading

TuesdayJul 23, 2019 12:09 pm

CannabisNewsBreaks – Supreme Cannabis Company Inc.’s (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) New Investment Platform Targets UK, European CBD Health and Wellness Sector

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recently launched a new investment platform called Supreme Heights. Established in London, the platform will capitalize on opportunities within the UK and European CBD health-and-wellness space. An article discussing the company reads, “While Supreme Heights has been initiated as a separate entity, the platform has solid foundational support and will benefit from Supreme Cannabis’ regulatory, product commercialization, supply chain, marketing and capital markets expertise, as well as corporate support services (http://cnw.fm/WgJ6O). Additionally, Supreme Heights will benefit from Supreme Cannabis’ experience launching premium brands and its team’s history of supporting health and wellness…

Continue Reading

FridayJul 19, 2019 2:59 pm

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Aims to Establish Significant Presence in Global Hemp, CBD Market

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, recently unveiled its plan to enter the global hemp-CBD market by announcing the launch of its Global Strategic Hemp Division.  An article discussing the company’s entrance into the global hemp-CBD market reads, “TGOD estimates that the global CBD market will reach $22 billion in less than three years. TGOD will move into the global sector as the demand for high-quality hemp-CBD products in Europe grows. In 2018, TGOD acquired HemPoland, which has an expanding footprint and distributor network across Europe. This move is expected to…

Continue Reading

FridayJul 19, 2019 2:41 pm

CannabisNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Swiftly Expanding Throughout the US

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3), a company with roots as a family-run business selling vape pens in Washington state, has transformed into an award-winning cannabis holding company with a multistate portfolio. An article discussing the company reads, “Headquartered in Washington, where it all began, the company is rapidly expanding throughout the United States, reaching first into Oregon, California and Nevada, with its products currently sold in 685 stores across six states, and plans in place to continue expansion into other states throughout the year. The company is focused on organic, bottom-up growth as it cultivates and delivers…

Continue Reading

FridayJul 19, 2019 1:03 pm

CannabisNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Appoints Seasoned Life Sciences Executive to Board of Directors

Geyser Brands (TSX.V: GYSR) announced key appointments to its leadership team recently, including the addition of Dr. Bin Huang to the company’s board of directors (http://cnw.fm/c6cFk). An article discussing the company reads, “Joining the board of directors is Dr. Bin Huang, a seasoned, life-sciences executive with experience in strategy and new business development, financing and public markets, corporate governance and operations management in North America and Asia. She most recently served as CEO of Emerald Health Therapeutics Inc. and has held senior-management roles in both startups and Fortune 500 corporations. Huang holds a PhD in plant cell biology from the University…

Continue Reading

FridayJul 19, 2019 12:47 pm

CannabisNewsBreaks – City View Green Holdings Inc.’s (CSE: CVGR) Retail Arm Expands Reach

City View Green Holdings (CSE: CVGR), together with Budd Hutt, the company’s retail arm, recently announced an agreement to acquire eight retail cannabis store locations in Alberta. An article discussing the company reads, “Budd Hutt plans to initially enter the Canadian retail cannabis marketplace through Alberta and intends to acquire eight pre-license retail cannabis store locations in the Alberta market. These stores have already obtained the appropriate regulatory approvals and are waiting on final approval from Alberta Gaming, Liquor and Cannabis (AGLC). On receipt of AGLC approval, all of the stores will be finished, with the initial five retail store…

Continue Reading

FridayJul 19, 2019 12:10 pm

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Employs Proprietary Biosynthetic Processes to Develop Ultra-Pure CBD

Canada-based Willow Biosciences (CSE: WLLW) was recently featured in a video by InvestmentPitch Media detailing how the company utilizes its proprietary biosynthetic processes to deliver high yields of ultra-pure, low-cost cannabinoids. An article further discussing the company reads, “The video (http://cnw.fm/7MJm1) highlights a recent joint development agreement between Alberta, Canada-based Willow Biosciences and Delaware-headquartered Noramco that will build on Willow’s experience in developing manufacturing processes for active pharmaceutical ingredients (‘APIs’) that treat conditions such as cancer, pain and central nervous system disorders, as well as Noramco’s experience in producing high-quality, synthetic cannabinoid APIs for the pharmaceutical and health care industry.…

Continue Reading